https://www.selleckchem.com/pr....oducts/trastuzumab-d
anism involved NF-κB-Snail pathway in cervical cancer. This might serve as a novel molecular therapeutic target for treating cervical cancer metastasis. IJCEP Copyright © 2020.No consensus has been achieved regarding the optimal extent of lymph node (LN) dissection for node-negative ESCC patients. This study aimed to determine the optimal extent of LN dissection for node-negative ESCC patients. We retrospectively reviewed 481 ESCC patients with node-negative resection and no preoperative therapy. Overall survival (OS) was
Aimer
Commentaire
Partagez
